These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6371640)

  • 1. [Diagnosis, prevention and treatment of infections of bacterial, fungal and viral origin in immunocompromised patients].
    Kurrle E; Schmeiser T
    Onkologie; 1984 Feb; 7 Suppl 1():37-45. PubMed ID: 6371640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing fungal and viral infection in the immunocompromised host.
    Jehn U
    Recent Results Cancer Res; 1988; 108():61-70. PubMed ID: 3051213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Infections in immunosuppressed children].
    Wiger K; Høiby EA; Wathne KO
    Tidsskr Nor Laegeforen; 2005 May; 125(9):1168-72. PubMed ID: 15880153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esophageal infections: etiology, diagnosis, and management.
    Wilcox CM; Karowe MW
    Gastroenterologist; 1994 Sep; 2(3):188-206. PubMed ID: 7987618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of bacterial and fungal infections in end stage liver disease and liver transplantation: Current options and future directions.
    Righi E
    World J Gastroenterol; 2018 Oct; 24(38):4311-4329. PubMed ID: 30344417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antimicrobial prophylaxis and therapy in neutropenia].
    Link H
    Mycoses; 2003; 46 Suppl 2():21-32. PubMed ID: 15055140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of infections in immunocompromised cancer patients.
    Bajetta E; Gasparini G; Monfardini S; Volonterio A; Buzzoni R; Shinde S
    Haematologica; 1984; 69(5):576-97. PubMed ID: 6437936
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibiotics in immunosuppressed patients.
    Tosolini FA
    Aust Fam Physician; 1979 Oct; 8(10):1087-97. PubMed ID: 518400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial resistance prevention initiative--an update: proceedings of an expert panel on resistance.
    Moellering RC; Graybill JR; McGowan JE; Corey L;
    Am J Infect Control; 2007 Nov; 35(9):S1-23; quiz S24-6. PubMed ID: 17980231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Office treatment of infection. 2. Nonrespiratory bacterial infections, antibiotic prophylaxis, fungal and viral infections.
    Fekety R
    Postgrad Med; 1980 Feb; 67(2):87-96. PubMed ID: 6892535
    [No Abstract]   [Full Text] [Related]  

  • 11. Advances in the prophylaxis and treatment of infections in immunocompromised patients (a symposium). Lausanne, 11. 3. 1983.
    Schweiz Med Wochenschr Suppl; 1983; 14():1-75. PubMed ID: 6581530
    [No Abstract]   [Full Text] [Related]  

  • 12. Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group.
    Wolff SN; Fay J; Stevens D; Herzig RH; Pohlman B; Bolwell B; Lynch J; Ericson S; Freytes CO; LeMaistre F; Collins R; Pineiro L; Greer J; Stein R; Goodman SA; Dummer S
    Bone Marrow Transplant; 2000 Apr; 25(8):853-9. PubMed ID: 10808206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Systemic fungal infections in immunocompromised patients].
    Zupanić-Krmek D; Nemet D
    Acta Med Croatica; 2004; 58(4):251-61. PubMed ID: 15700680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fungal and bacterial infections in the immunocompromised host.
    Rubin RH
    Eur J Clin Microbiol Infect Dis; 1993; 12 Suppl 1():S42-8. PubMed ID: 8477762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of mycoses in surgical patients -- review of the literature.
    Holzheimer RG; Dralle H
    Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic therapy in the management of infections in dental patients.
    Gardner AF
    Ann Dent; 1982; 41(1):7-22. PubMed ID: 6965042
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of antifungal therapy in hospitalized patients. I. Results prior to the marketing of fluconazole.
    Grasela TH; Goodwin SD; Pasko MT; Walawander CA; Raebel MA
    Ann Pharmacother; 1994 Feb; 28(2):252-60. PubMed ID: 8173147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of systemic mycoses in immunodeficiency].
    Just-Nübling G; Stille W
    Immun Infekt; 1991 Aug; 19(4):116-20. PubMed ID: 1937558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention and therapy of infections in tumor patients].
    Burgmann H
    Wien Med Wochenschr; 2001; 151(24):600-14. PubMed ID: 11820177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infections in patients with multiple myeloma.
    Nucci M; Anaissie E
    Semin Hematol; 2009 Jul; 46(3):277-88. PubMed ID: 19549580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.